StrokeTPQ BDI SSQOLNCT00845455
Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.
An observational study of Stroke and Depression, run by d_yarnitsky.
Trial summary
Personality type as a predictor to develop depression and reduction in quality of life among stroke survivals. Read more about this study
- Who is it for?
- Ages 40 to 90 years
- Conditions the study is for
- Stroke, Depression, Quality of Life
- How many people
- 85 participants
- Where
- No sites listed yet
- Study dates
- Nov 2007to Jun 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Stroke ( TIA, CVA, ICH ) patients
Who may be able to join
- any stroke,
- age 40-90,
- able to sigh informed concent,
- able to fill in the questionnaires.
Who cannot join
- non stroke,
- previous depression,
- not able to give consent or answer the questions.
About this study
Personality type as a predictor to develop depression and reduction in quality of life among stroke survivals.
- Conditions
- Stroke, Depression, Quality of Life, Personality Type
- Medical subject headings
- Stroke, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1. Harm Avoidance | Personality type | |
| 2. Reward Dependence | Personality type | |
| 3. Novelty Seeking | Personality type |
What is being measured
The primary outcome is the main question the study is designed to answer.
Depression
Measured: 1-3 month post stroke
Secondary outcomes (1)
QOL post stroke
Measured: 1-3 month post stroke
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Feb 2009 (estimated)
- Study startNov 2007
- Primary completionJun 2009
- Study completionJun 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 85 participants (actual)
Sponsor and investigators
- Lead sponsor
- d_yarnitsky
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, d_yarnitsky, Rambam Health Care Campus
- Investigators
- David - Yarnitsky, Prof., Principal investigator
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00845455
- Sponsor's protocol ID
- TPQStroke03CTIL
- Acronym
- TPQ BDI SSQOL
- Status last verified
- Oct 2011
- First submitted
- 15 Feb 2009
- Last updated
- 25 Oct 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Oct 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.
- ClinicalTrials.gov ID
- NCT00845455
- Acronym / sponsor ID
- TPQ BDI SSQOL / TPQStroke03CTIL
- Conditions
- Stroke, Depression, Quality of Life, Personality Type
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 85 participants (actual)
- Lead sponsor
- d_yarnitskyUniversity, hospital or other
- Study start
- Nov 2007
- Primary completion
- Jun 2009 (actual)
- Study completion
- Jun 2009 (actual)
- First posted
- 18 Feb 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Personality type as a predictor to develop depression and reduction in quality of life among stroke survivals.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| 1. Harm Avoidance | – | –Personality type |
| 2. Reward Dependence | – | –Personality type |
| 3. Novelty Seeking | – | –Personality type |
Who may qualify
- Ages
- 40 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Stroke ( TIA, CVA, ICH ) patients
Key inclusion criteria (4 listed)
- any stroke,
- age 40-90,
- able to sigh informed concent,
- able to fill in the questionnaires.
Key exclusion criteria (3 listed)
- non stroke,
- previous depression,
- not able to give consent or answer the questions.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Depression
Time frame: 1-3 month post stroke
1 secondary outcome
QOL post stroke
Time frame: 1-3 month post stroke
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Oct 2011.
Related trials for Stroke
Not yet recruiting
Foot Drop Rehabilitation and Mobility in Chronic Stroke
Stroke
Enrolling by invitation
Study on the Efficacy and Safety of Non-Invasive Brain-Computer Interface With MRI-Guided Multi-Channel Time-Domain Interference Stimulation in Treating Motor Dysfunction in Acute Cerebral Infarction Patients
Acute Ichemic Stroke
RecruitingObservational study
Development, Validation and Normative Data of the Italian Battery for the Recognition of Famous Faces (FAME)
Stroke, Alzheimer s Disease
Enrolling by invitation
Long-Term Clinical, Health Economic, and Process Evaluation of Intensive Technology-Integrated Motor Rehabilitation in Chronic Neurological Conditions (INTeRAcT-bis)
Stroke, Spinal Cord Injuries (SCI)
Not yet recruitingPhase 2
Rimonabant for Improving Walking Ability in Patients With Chronic Stroke
Chronic Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David - Yarnitsky, Prof. principal investigator
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke and Depression, run by d_yarnitsky.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Oct 2011. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Depression (time frame: 1-3 month post stroke). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2011.